NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 0.8400
-0.0200 (-2.33%)
Sep 11, 2026, 5:35 PM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €10.64 million as of September 11, 2026. Its market cap has decreased by -34.58% in one year.
Market Cap
10.64M
Enterprise Value
9.03M
Revenue
188.00
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.84
ChartMarket Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 10.64M, a decrease of -45.34%. That is a compound annual growth rate of -10.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 10.64M | -28.69% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 26.12M |
| genOway Société anonyme | 23.05M |
| Aelis Farma | 13.79M |
| Advicenne | 12.85M |
| Aton | 11.76M |
| TME Pharma | 10.11M |
| Poxel | 9.69M |
| Biophytis | 6.12M |